EOSINOPHILIC ESOPHAGITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

Published In: 29 Apr, 2026
Code: CMI4909
Page number: 207
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Recent Product Approval/Launch
- PEST Analysis
- Epidemiology
Global Eosinophilic Esophagitis Market, By Drug Class, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    - Budesonide
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
        
        Jorveza
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
        
        Off-label budesonide
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Fluticasone
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Proton Pump Inhibitor (PPI)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    - Omeprazole
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Esomeprazole
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Others
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Late Stage Pipeline Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
    - Dupixent
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - APT-1012
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Lirentelimab (AK002)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Cendakimab
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Etrasimod
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - TAK-721
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
    - Omilancor (BT-11)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Global Eosinophilic Esophagitis Market, By Distribution Channel, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Global Eosinophilic Esophagitis Market, By Region, 2021 – 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2029 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
    - U.K.
    - Germany
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Ellodi Pharmaceuticals.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - EsoCap AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - GlaxoSmithKline plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Teva Pharmaceutical Industries Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Cipla Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sun Pharmaceutical Industries Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AstraZeneca Plc
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sanofi S.A.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Arena Pharmaceuticals, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Revolo Biotherapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Allakos Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Bristol-Myers Squibb Co
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Calypso Biotech
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - DBV Technologies
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Landos Biopharma, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Glenmark Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Alkem Laboratories Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Quorum Innovations LLC
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
  - Falk Pharma GmbH
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Strategies
Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
Section
- References
- Research Methodology
- About Us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now